Taken together, these experiments show that Nucl-TAP downregulates TAP in tumor cells in vitro and in vivo, and recapitulates the phenotype of TAP-deficient cells in terms of selective downregulation of MHC class Ia expression and presentation of a common novel epitope. The gene discussed is UACA; the disease is neoplasm.